Arsenic and bladder cancer: Observations and suggestions

Journal of Environmental Health

Volumn 71, Issue 3, 2008, Pages 40-42

  Radosavljević, Vladan ^a,b,c   Jakovljević, Branko ^d  

^a Epidemiology Department

^b Institute of Preventive Medicine   (India)

^c Military Institute of Preventive Medicine   (Serbia)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; FRESH WATER;

ABSORPTION; ARSENIC; CANCER; DRINKING WATER; FOOD INTAKE; HEALTH RISK; METABOLISM; METHYLATION; POLLUTION EXPOSURE; RISK FACTOR;

ARSENIC POISONING; BLADDER TUMOR; CHEMICALLY INDUCED DISORDER; CHEMISTRY; ENVIRONMENTAL EXPOSURE; HUMAN; LIFESTYLE; METABOLISM; REVIEW; RISK FACTOR; SMOKING;

ARSENIC; ARSENIC POISONING; ENVIRONMENTAL EXPOSURE; FRESH WATER; HUMANS; LIFE STYLE; RISK FACTORS; SMOKING; URINARY BLADDER NEOPLASMS;

EID: 55349093593     PISSN: 00220892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Apostoli, P., Alessio, L., Romeo, L., Buchet, J.P., & Leone, R. (1997). Metabolism of arsenic after acute occupational arsine intoxication. Journal of Toxicology and Environmental Health, 52(4), 331-342.
2. Basu, A., Mahata, J., Gupta, S., & Giri, A.K. (2001). Genetic toxicology of a paradoxical human carcinogen, arsenic: A review. Mutation Research, 488(2), 171-194.
3. Brown, C.C., & Chu, K.C. (1983). Implications of the multistage theory of carcinogenesis applied to occupational arsenic exposure. Journal of the National Cancer Institute, 70(3), 455-463.
4. Chen, Y.C., Amarasiriwardena, C., Hsueh, Y.M., & Christiani, D. (2002). Stability of arsenic species and insoluble arsenic in human urine. Cancer Epidemiology, Biomarkers & Prevention 11(11), 1427-1433.
5. Janković, S., & Radosavljević, V. (2007). Risk factors for bladder cancer. Tumori, 93(1), 4-12.
6. Meacher, D., Menzel, D., Dillencourt, M., Bic, L., Schoof, R., Yost, L., Eickhoff, J., & Farr, C. (2002). Estimation of multimedia inorganic arsenic intake in the U.S. population. Human and Ecological Risk Assessment, 8, 1697-1721.
7. Meliker, J., Franzblau, A., Slotnick, M., & Nriagu, J. (2006). Major contributors to inorganic arsenic intake in southeastern Michigan. International Journal of Hygiene and Environmental Health, 209(5), 399-411.
8. Natural Resources Defense Council. (1999, March). Bottled water: Pure drink or pure hype? NRDC Report. Retrieved November 1, 2004, from www.nrdc.org
9. Radosavljević, V. (2004). Fluid balance, diet, and bladder cancer occurrence. European Journal of Cancer Prevention: The official journal of the European Cancer Prevention Organisation (ECP), 13(2), 151.
10. Roy, P., & Saha, A. (2002). Metabolism and toxicity of arsenic: A human carcinogen. Current Science, 2(1), 38-45.
11. Schoen, A., Beck, B., Sharma, R., & Dubé, E. (2004). Arsenic toxicity at low doses: epidemiological and mode of action considerations. Toxicology and Applied Pharmacology, 198(3), 253-367.
12. Smith, C.J., Livingston, S.D., & Doolittle, D.J. (1997). An international literature survey of "IARC Group I Carcinogens" reported in mainstream cigarette smoke. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association, 35(10-11), 1107-1130.
13. Steinmaus, C., Yuan, Y., Kalman, D., Atallah, R., & Smith, A. (2005). Intraindividual variability in arsenic methylation in a U.S. population. Cancer Epidemiology, Biomarkers & Prevention, 14(4), 919-924.
14. Wang, Z., & Rossman, T.G. (1996). The carcinogenicity of arsenic. In L.W. Chang, L. Magos, & T. Suzuki (Eds.), Toxicology of metals (pp. 221-229). Boca Raton, Florida: CRC Press.